2P-0562 Rosuvastatin reduces atherosclerosis development beyond and independently of its plasma cholesterol-lowering effect in APOE∗3-Leiden transgenic mice. Evidence for anti-inflammatory effects of rosuvastatin

2003 ◽  
Vol 4 (2) ◽  
pp. 162-163
Author(s):  
L. Havekes ◽  
R. Kleemann ◽  
J. Emeis ◽  
R. Fontijn ◽  
A. Horrevoets ◽  
...  
Keyword(s):  
Transgenic Mice ◽  
Plasma Cholesterol ◽  
Cholesterol Lowering ◽  
Lowering Effect ◽  
Anti Inflammatory ◽  
Atherosclerosis Development ◽  
Cholesterol Lowering Effect

scholarly journals Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol–Lowering Effect in APOE*3-Leiden Transgenic Mice

Circulation ◽  
2003 ◽  
Vol 108 (11) ◽  
pp. 1368-1374 ◽  
Author(s):  
Robert Kleemann ◽  
Hans M.G. Princen ◽  
Jef J. Emeis ◽  
J. Wouter Jukema ◽  
Ruud D. Fontijn ◽  
...  
Keyword(s):  
Transgenic Mice ◽  
Plasma Cholesterol ◽  
Cholesterol Lowering ◽  
Lowering Effect ◽  
Atherosclerosis Development ◽  
Cholesterol Lowering Effect
Sign in / Sign up

Export Citation Format

Share Document